Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures (HONEST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03932396
Recruitment Status : Unknown
Verified April 2019 by Instituto de Investigación Marqués de Valdecilla.
Recruitment status was:  Not yet recruiting
First Posted : April 30, 2019
Last Update Posted : April 30, 2019
Sponsor:
Information provided by (Responsible Party):
Instituto de Investigación Marqués de Valdecilla

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice.

Condition or disease Intervention/treatment
Hepatotropic Virus Infection Addictive Behaviours o Conducts Mental Disease People Sentenced to Non-custodial Sentences Other: Observational study

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures
Estimated Study Start Date : May 10, 2019
Estimated Primary Completion Date : March 1, 2021
Estimated Study Completion Date : March 31, 2021

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Single group of subjects who fulfill the inclusion criteria
All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (CIS) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).
 Other: Observational study
No intervention is planned outside of usual clinical practice. Only active screening for hepatotropic virus infection, mainly hepatitis C virus, HIV, and mental illness will be carried out. If any disease is detected, patients will be referred to the corresponding specialized care following the usual clinical practice.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Number of subjects screened for anti-HCV [ Time Frame: From march of 2019 to march of 2021 ]
  2. Percentage of anti-HCV positive [ Time Frame: From march of 2019 to march of 2021 ]
  3. Number of anti-HCV positive subjects with detectable viremia [ Time Frame: From march of 2019 to march of 2021 ]
  4. Percentage of subjects with detectable viremia [ Time Frame: From march of 2019 to march of 2021 ]
  5. To detect other comorbidities such as mental disorders, drug dependencies in this population and link these patients with specific health care programs of Penitentiary Institutions (Extended Bridge Program) and the Government of Cantabria (Chronicity and [ Time Frame: From march of 2019 to march of 2021 ]
  6. Number of subjects screened for mental illness. [ Time Frame: From march of 2019 to march of 2021 ]
  7. Percentage of subjects with mental illness [ Time Frame: From march of 2019 to march of 2021 ]
  8. Number of subjects screened for drug addiction [ Time Frame: From march of 2019 to march of 2021 ]
  9. Percentage of subjects with drug addiction [ Time Frame: From march of 2019 to march of 2021 ]
  10. Number of subjects linked to the Chronicity Program of the Government of Cantabria [ Time Frame: From march of 2019 to march of 2021 ]
  11. Percentage of subjects linked to the Chronicity Program of the Government of Cantabria [ Time Frame: From march of 2019 to march of 2021 ]
  12. Number of subjects linked to the Extended Bridge program of Penitentiary Institutions [ Time Frame: From march of 2019 to march of 2021 ]
  13. Percentage of subjects linked to the Extended Bridge program of Penitentiary Institutions [ Time Frame: From march of 2019 to march of 2021 ]
  14. Number of subjects served by the Navigator [ Time Frame: From march of 2019 to march of 2021 ]
  15. Number of subjects with an average rating greater than 4 on a Likert scale of 5 points of satisfaction with the Navigator [ Time Frame: From march of 2019 to march of 2021 ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 79 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All the population condemned to a non-custodial sentence that is presented in the Service of Management of Penalties and Alternative Measures of the Center of Social Insertion (SIC) José Hierro CP Dueso during the study period (March 2019 and March 2021) , with ages between 18 and 79 years (approximately 1000 people / year) and willing to participate (signs the IC).
Criteria

Inclusion Criteria:

  • the entire population served in the Management of Penalties and Alternative Measures Service (SGPMA) of the José Hierro SIC, including new admissions within the study period.

Exclusion Criteria:

  • they are not willing to participate and do not sign informed consent.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03932396


Contacts
Layout table for location contacts
Contact: Antonio Cuadrado Lavín, MD 942202544 antonio.cuadrado@scsalud.es
Contact: Lucía Lavín Alconero, Bsc,PhD 942203373 eclinicos5@idival.org

Locations
Layout table for location information
Spain
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain, 39008
Contact: Antonio Cuadrado Lavín, MD    942202544    antonio.cuadrado@scsalud.es   
Sponsors and Collaborators
Instituto de Investigación Marqués de Valdecilla
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Other Publications:

Layout table for additonal information
Responsible Party: Instituto de Investigación Marqués de Valdecilla
ClinicalTrials.gov Identifier: NCT03932396    
Other Study ID Numbers: HONEST
First Posted: April 30, 2019    Key Record Dates
Last Update Posted: April 30, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Instituto de Investigación Marqués de Valdecilla:
hepatitis C virus
non-custodial sentences
addictive behaviours
Mental disease
 Navigator
screening
POCT
Additional relevant MeSH terms:
Layout table for MeSH terms
Hepatitis C
Hepatitis
Behavior, Addictive
Mental Disorders
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
 Infections
RNA Virus Infections
Blood-Borne Infections
Communicable Diseases
Flaviviridae Infections
Compulsive Behavior
Impulsive Behavior